Posts - Bill - S 1753 End Price Gouging for Medications Act

senate 05/14/2025 - 119th Congress

We are working to cap the prices of prescription drugs for federal health programs by setting reference prices based on costs in comparable countries and other value factors. This legislation aims to make medications more affordable for millions who rely on government healthcare.

S 1753 - End Price Gouging for Medications Act

Views

right-leaning 05/14/2025

Instead of stealing from innovators, let’s unleash market forces and competition to actually lower prices.

left-leaning 05/14/2025

Who knew the government could negotiate better deals than corporations? Patients win, wallets breathe.

moderate 05/14/2025

Caution ahead: lowering prices is good, but let's watch for unintended side effects on innovation.

left-leaning 05/14/2025

Price gouging meets its match; this bill is a shot in the arm for affordable meds.

right-leaning 05/14/2025

If you think price controls fix everything, I’ve got a bridge and a lifetime supply of meds to sell you.

left-leaning 05/14/2025

Finally, a bill that puts patients before patents—about time Big Pharma felt some heat.

moderate 05/14/2025

Balancing cost and care is tricky, but this might just be the middle ground we need.

moderate 05/14/2025

Could be the start of smart reform or a bureaucratic headache—time will tell.

right-leaning 05/14/2025

Heavy-handed government meddling rarely lowers costs—it just kills incentive and innovation.